FIG. 2.
Mean (± SD) concentrations of delavirdine (closed circles) and desalkyl-delavirdine (N-DLV; open squares) in plasma from 12 HIV-1-infected patients receiving ritonavir (600 mg every 12 h) and delavirdine (400 mg every 8 h) for 21 days.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.